angiotensin-ii

Documents about angiotensin-ii

• Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia#831630ClinicalTrials.gov
• Renin and Renal Biomarker Response to Angiotensin II#897636ClinicalTrials.gov
• Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease#948231Repositorio de Universidad Autónoma de Chile.
• Angiotensin II Infusion Leads to Aortic Dissection in LRP8 Deficient Mice#235338HAL (France)
• Angiotensin II in Liver Transplantation#834523ClinicalTrials.gov
• Postoperative Pain and Angiotensin II Receptor Antagonists#454117ClinicalTrials.gov
• Angiotensin II Receptor: Molecular Cloning, Functions, and Regulation#70532J-STAGE (Japan)
• Angiotensin II for Septic Shock Treatment#807491ClinicalTrials.gov
• Angiotensin II Pathway and Postoperative Hypoxemia#992389ClinicalTrials.gov
• Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database#947907Repositorio de Universidad Autónoma de Chile.
• Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock#839981ClinicalTrials.gov
• Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)#828056ClinicalTrials.gov
• Angiotensin II Blockade for Chronic Allograft Nephropathy#238275ClinicalTrials.gov
• Cardioprotective mechanisms against reperfusion injury in acute myocardial infarction: targeting angiotensin II receptors#250639IRIS
• MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2#70373J-STAGE (Japan)
• Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy#875209ClinicalTrials.gov
• Study of Renin-angiotensin System in Mechanically Ventilated Subjects#897408ClinicalTrials.gov
• New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering#366667ClinicalTrials.gov
• Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II#897139ClinicalTrials.gov
• A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.#805635ClinicalTrials.gov
• Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics#910524ClinicalTrials.gov
• Plasma Angiotensin II Levels In Women With Type 2 Diabetes With Or Without Hypertension#930366Acta Interna: The Journal of Internal Medicine
• A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)#136157ClinicalTrials.gov
• Codelist for: "Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study"#274972LSHTM Data Compass
• Angiotensin II Type 1 Receptor Autoantibodies (AT1AA): Cause or Consequence of Human Primary Aldosteronism?#647608Research Data Unipd
• Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients#442020ClinicalTrials.gov
• YK-4-250 Mitigates Gastrointestinal Radiation Syndrome and Promotes Overall Survival Following Partial Body Radiation Injury#393078ODU Digital Commons
• Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients#908180ClinicalTrials.gov
• PTH Biosynthesis Regulation by Aldosterone and Angiotensin II is Blunted in Human Hyperaldosteronism and Rescued by Adrenalectomy#647602Research Data Unipd
• Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.#874807ClinicalTrials.gov
• Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis#968525ClinicalTrials.gov
• Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance#830525ClinicalTrials.gov
• Identification and Synergism of cis-acting Elements Essential for Basal Promoter Activity of the Human Type 1 Angiotensin II Receptor Gene in PLC-PRF-5 Cells#70211J-STAGE (Japan)
• A redox sensor in protein kinase A regulatory subunit Iα regulates vasodilation and protects against hypertension#121213Europe PMC
• WATER-ELECTROLYTE BALANCE AND ITS PHYSIOLOGICAL IMPORTANCE#195271Zenodo (CERN)
• Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome#314433ClinicalTrials.gov
• Conserved Transcriptional Circuits Regulate Cardiac Fibroblast-Mediated Fibrosis#464137Figshare
• GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence#844061ClinicalTrials.gov
• Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood#968533ClinicalTrials.gov
• Local Vasoconstriction in Postural Tachycardia Syndrome#1009195ClinicalTrials.gov
• Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency#686901Spiral
• Enhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxia#948949Repositorio de Universidad Autónoma de Chile.
• Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress.#372165Repisalud
• Adiponectin in Obese Women With T2DN and Effects by RAS Blocker#831197ClinicalTrials.gov
• Multilayered interplay between fructose and salt in development of hypertension: what has been revealed so far#955641Koc University Digital Collections
• Regulatory networks and complex interactions between the insulin and angiotensin II signalling systems: models and implications for hypertension and diabetes#954584Koc University Digital Collections